Expert | Jotup

ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024

Retrieved on:

Thursday, March 21, 2024

IRVINE, Calif., March 21, 2024 /PRNewswire/ -- Allergan Aesthetics demonstrates its ongoing commitment to originality and its bold approach to aesthetics at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from Wednesday, March 27– Friday, March 29, 2024. Events include two Allergan Medical Institute (AMI) symposia, Science of AgingTM event, Meet the Expert presentations, poster sessions and an interactive exhibition booth.

Key Points:

"AMWC presents an invaluable opportunity to meet with esteemed experts from across the globe," said Carrie Strom, President, Global Allergan Aesthetics.
As industry pioneers, Allergan Aesthetics has been at the forefront of uncovering the trends that are shaping aesthetics.
Centering around its True Originals theme, Individuality, Innovation and Integrity, Allergan Aesthetics is shaping the future of the aesthetics industry.
The first symposium, 'True Originals: A Personalised Approach with the Allergan Aesthetics Range', focuses on an in-depth look into patient needs.

Google Canada announces new research grants to bolster Canada's AI ecosystem

Retrieved on:

Monday, March 18, 2024

From its first-rate education system to world-class researchers, there's been a surge in AI knowledge and expertise over the last decade.

Key Points:

From its first-rate education system to world-class researchers, there's been a surge in AI knowledge and expertise over the last decade.
"We look forward to supporting these organizations to propel Canada's AI momentum and shape a brighter future that benefits all Canadians."
The funding will also support CIFAR's work to promote responsible AI research and development.
"Advancing Responsible AI is a core tenet of CIFAR's work through the Pan-Canadian AI Strategy," said Elissa Strome, Executive Director, Pan-Canadian AI Strategy at CIFAR.

Nucleus Research Releases 2024 Data Platform Technology Value Matrix

Retrieved on:

Tuesday, February 20, 2024

Select vendors are also extending the scope of their data platforms into data science and data management to better support end-to-end analytics initiatives.

Key Points:

Select vendors are also extending the scope of their data platforms into data science and data management to better support end-to-end analytics initiatives.
The Experts in this year’s Value Matrix are organizations that deliver value to customers with complex use cases through deep functionality and industry-specific capabilities.
Accelerators in this year’s Value Matrix deliver value through greater ease of use and quick implementation.
To download the full 2024 Data Platform Technology Value Matrix, click here .

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on:

Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points:

H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on:

Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points:

H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

DeepScribe Launches New and Innovative Trust and Safety Suite for its Ambient AI Technology

Retrieved on:

Wednesday, February 14, 2024

Bias, SAN, SOC 2, AI, Ethics, Safety, Covenant, Saginaw, Michigan, Expert, Trust, Patient, Moment, SOC, AWS, Medical device

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- DeepScribe, a leader in AI-powered medical documentation solutions, announced today its new Trust and Safety Suite. The innovative features in DeepScribe's latest addition to its ambient AI technology reflect the company's initiative to set industry standards for AI in healthcare in safety, transparency, and ethics, and ensure that AI advancements are as trustworthy as they are revolutionary.

Key Points:

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- DeepScribe, a leader in AI-powered medical documentation solutions, announced today its new Trust and Safety Suite.
The innovative features in DeepScribe's latest addition to its ambient AI technology reflect the company's initiative to set industry standards for AI in healthcare in safety, transparency, and ethics, and ensure that AI advancements are as trustworthy as they are revolutionary.
"Since inception, DeepScribe has been unwaveringly dedicated to trust and safety, and this commitment extends beyond the introduction of our new Trust and Safety Suite," stated Akilesh Bapu, DeepScribe CEO.
To learn more about DeepScribe's Trust and Safety Suite and its commitment to ethical AI, visit www.deepscribe.ai/trustandsafety .

Nucleus Research Releases 2024 Corporate Performance Management Technology Value Matrix

Retrieved on:

Tuesday, February 6, 2024

Solution’s breadth of functionality remains a key focus in the Corporate Performance Management (CPM) market.

Key Points:

Solution’s breadth of functionality remains a key focus in the Corporate Performance Management (CPM) market.
The Experts in this year’s Value Matrix are organizations that deliver value to customers with complex use cases through deep functionality and industry-specific capabilities.
Accelerators in this year’s Value Matrix deliver value through greater ease of use and quick implementation.
To download the full 2024 CPM Technology Value Matrix, click here .

MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers

Retrieved on:

Tuesday, January 30, 2024

Partnership, Cell engineering, LBL, Orphan drug, Expert, NK, Patient, Transfection, Adolescence, NCT, MBA, Food, Cancer, CD7, Doctor of Philosophy, SPL, Pharmaceutical industry

Under the terms of the agreement, Wugen gains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform.

Key Points:

Under the terms of the agreement, Wugen gains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform.
Wugen is developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer.
The company’s investigational cell therapies originate from healthy donors and are further engineered to enhance their function of eliminating cancer cells.
Wugen is MaxCyte’s 26th clinical/commercial partnership overall, each of which generates pre-commercial milestone revenue, the vast majority of which includes sales-based payments.

Dr. Husam Almunajed Continues Partnership With Haute Beauty Network

Retrieved on:

Friday, February 2, 2024

Partnership, Cosmetic, Life, Dental implant, Clinical, Teaching, Expert, Patient, Dental care, Georgetown University, Villanova University, Align Technology, Education, University, Dentist, Dentistry

NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Husam Almunajed is a highly skilled cosmetic and restorative dentist who has made a name for himself in creating beautiful and healthy smiles for his patients. With an undergraduate degree from Villanova University and a master's degree from Georgetown University, Dr. Almunajed continued his education at the University of Connecticut School of Dental Medicine, where he completed his dental degree and a 2-year residency focused on comprehensive dental care.

Key Points:

Smile Expert from New York, Dr. Husam Almunajed, continues his partnership with Haute Beauty Network, now in his sixth year.
"With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry."
With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry.
As he continues to teach and mentor the next generation of dentists, Dr. Almunajed's legacy of excellence in dentistry will undoubtedly continue to grow.

Dr. Samuel Lin Continues Partnership With Haute Beauty Network

Retrieved on:

Friday, February 2, 2024

NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts. Dr. Lin received his Bachelor's degree in Biomedical Engineering at Northwestern University and was enrolled in the Honors Program for Medical Education at Northwestern University, Feinberg School of Medicine, Chicago, Illinois. He then completed a five-year-residency in Otolaryngology-Head and Neck Surgery followed by a three-year-residency in Plastic and Reconstructive Surgery at Northwestern Memorial Hospital. This was followed by a one-year fellowship appointment in Microvascular Reconstructive Surgery at the world-renowned University of Texas M.D. Anderson Cancer Center in Houston, Texas. Throughout the course of his training, Dr. Lin gained state-of-the-art skills in a multitude of reconstructive and cosmetic procedures with his background in Head and Neck Surgery providing him with additional expertise in Plastic and Reconstructive Surgery. He has also been named a Top Influencer in #PlasticSurgery.

Key Points:

Nose Expert from Boston, Dr. Samuel Lin, continues his partnership with Haute Beauty Network, now in his sixth year.
NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts.
Dr. Lin is board certified by both the American Board of Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery.
Dr. Lin, his team, and his collaborators regularly publish scientific papers in the literature to further knowledge about plastic surgery and other topics.